Records containing: Hepatitis C
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-03-27Multicenter Study To Evaluate The Efficacy Of Silymarin In Addition To Combination-Therapy With Pegylated Interferon Alfa 2a (Peg-Ifn Alfa 2a) And Ribavirin In Patients With Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2017-03-23The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital
-
CLINICAL_TRIALS study record update · 2017-03-20The Impact of Peginterferon Alpha-2a Maintenance Therapy on Portal Hypertension in Patients With Chronic Hepatitis C Virus Infection and Advanced Fibrosis and Cirrhosis Enrolled in the HALT-C Trial
-
CLINICAL_TRIALS study record update · 2017-03-20An Open-label, Randomized Pilot Study to Compare the Effectiveness of Peginterferon-alfa-2b Plus Ribavirin to Peginterferon-alfa-2b Plus Epoetin-alfa and Two Doses of Ribavirin in the Treatment of Chronic Hepatitis C Virus Infection
-
CLINICAL_TRIALS study record update · 2017-03-20An Open Label Study Assessing SVR and Viral Resistance Profile With Boceprevir Plus PEG-IFN Plus Ribavirin Triple Therapy in HCV-1 Infected Patients With Insulin Resistance Who Have Failed PEG-IFN Plus Ribavirin Dual Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-03-13Study to Confirm Dose Response With PegIntron (SCH 54031) Monotherapy in Patients With Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2017-03-01Chronic Hepatitis Intervention Project for Drug Users
-
CLINICAL_TRIALS study record update · 2017-02-23Open-label Study of Efficacy and Safety of Generic Sofosbuvir/Ledipasvir±Ribavirin in Iranian Patients With Hepatitis C Virus Genotype 1 Infection
-
CLINICAL_TRIALS study record update · 2017-02-20A Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Patients Undergoing Antiviral Therapy for Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2017-02-16Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods
-
CLINICAL_TRIALS study record update · 2017-02-16A Prospective 3-Year Follow-up Study in Subjects Previously Treated in a Phase IIb or Phase III Study With a TMC435-Containing Regimen for the Treatment of Hepatitis C Virus (HCV) Infection
-
CLINICAL_TRIALS study record update · 2017-02-10Armodafinil for Patients Starting Hepatitis C Treatment
-
CLINICAL_TRIALS study record update · 2017-01-30HBV Prevention for Homeless at Risk for HBV/HCV/HIV
-
CLINICAL_TRIALS study record update · 2017-01-27Open-Label, Randomized Study of Daclatasvir, Sofosbuvir, and Ribavirin for 12 vs. 16 Weeks in Treatment Naive and Treatment Experienced Patients With Genotype 3 Chronic Hepatitis C Infection Subjects With Compensated Advanced Fibrosis/Cirrhosis (F3/F4)
-
CLINICAL_TRIALS study record update · 2017-01-27Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers
-
CLINICAL_TRIALS study record update · 2017-01-27Impact of Immune Responses in Chronic Hepatitis C Genotype 1,2,3 Virus Infected Patients During Treatment With Pegylated Interferon-alpha-2b and Ribavirin (CIRES).
-
CLINICAL_TRIALS study record update · 2017-01-23A Randomized, Double-Blind, Pbo-Controlled, Study of EDP-494 to Evaluate the Safety and PK of SAD/FE in Healthy Subjects and MAD in Healthy and in Subjects With CHC Infection (POC)
-
CLINICAL_TRIALS study record update · 2017-01-19A Phase III Double Blind Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects With Chronic HCV GT1, GT4 and GT6 Infection With Inherited Blood Disorders With and Without HIV Co-Infection
-
CLINICAL_TRIALS study record update · 2017-01-16HCV Treatment of IDUs After Buprenorphine Stabilization
-
CLINICAL_TRIALS study record update · 2017-01-16A Randomized, Open Label Trial of the Safety and Efficacy of DEB025/Alisporivir in Combination With Pegylated Interferon-α2a and Ribavirin (Peg-INFα2a/RBV) and Boceprevir in Combination With Peg-INFα2a/RBV in African American Treatment-naïve Patients With Chronic Hepatitis C Genotype 1
-
CLINICAL_TRIALS study record update · 2017-01-12An Open-Label, Randomized, Prospective Multicenter Study To Compare The Efficacy And Safety Among 3 Immunosuppressant Treatment Regimens In Patients Receiving A Liver Transplant For ESLD Caused By Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2017-01-12Preventing Depression in MMT Patients on Interferon
-
CLINICAL_TRIALS study record update · 2017-01-11Behavioral Intervention Trial to Reduce Transmission Risks and Improve HCV Treatment Access Among HCV-infected Injection Drug Users
-
CLINICAL_TRIALS study record update · 2017-01-11A Phase III, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 Versus Sofosbuvir/Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and PR Prior Treatment Failure Subjects With Chronic HCV GT1, 4 or 6 Infection
-
CLINICAL_TRIALS study record update · 2017-01-09The Effect of Omega-3 Fatty Acids (Omacor@) on the Response Rate to Antiviral Therapy in Patients With Chronic Hepatitis C Infection